JNK Inhibitors

JNK1

JNK2

JNK3

JNK

JNK Inhibitors & Activators

Product Name	JNK1	JNK2	JNK3	JNK	Purity
SP600125	JNK1, IC₅₀: 40 nM	JNK2, IC₅₀: 40 nM	JNK3, IC₅₀: 90 nM		99.73%
Anisomycin				JNK	99.44%
JNK-IN-8	JNK1, IC₅₀: 4.7 nM	JNK2, IC₅₀: 18.7 nM	JNK3, IC₅₀: 1 nM		99.67%
Chloramphenicol				JNK	99.82%
Astragaloside IV				JNK	≥98.0%
Guggulsterone				JNK	99.95%
JNK Inhibitor VIII	JNK1, Ki: 2 nM JNK1, IC₅₀: 45 nM	JNK2, Ki: 4 nM JNK2, IC₅₀: 160 nM	JNK3, Ki: 52 nM		99.46%
Tanzisertib	JNK1, IC₅₀: 61 nM	JNK2, IC₅₀: 7 nM	JNK3, IC₅₀: 6 nM		99.87%
Tomatidine				JNK	≥98.0%
CC-90001	JNK1	JNK2			99.85%
Ginsenoside Re				JNK	98.04%
JNK-IN-7	JNK1, IC₅₀: 1.5 nM	JNK2, IC₅₀: 2 nM	JNK3, IC₅₀: 0.7 nM		98.92%
Bentamapimod	JNK1, IC₅₀: 80 nM	JNK2, IC₅₀: 90 nM	JNK3, IC₅₀: 230 nM		99.32%
AS601245	hJNK1, IC₅₀: 150 nM	hJNK2, IC₅₀: 220 nM	hJNK3, IC₅₀: 70 nM		98.83%
Isovitexin	JNK1	JNK2			99.82%
DB07268	JNK1, IC₅₀: 9 nM				99.92%
D-JNKI-1				JNK	98.47%
SR-3306				JNK	99.0%
CC-401 hydrochloride				JNK, Ki: 25-50 nM	99.46%
BI-78D3				JNK, IC₅₀: 280 nM	99.49%
Seratrodast				JNK	98.86%
J30-8			JNK3, IC₅₀: 40 nM		99.90%
TCS JNK 5a		JNK2, pIC₅₀: 6.5	JNK3, pIC₅₀: 6.7		98.96%
Juglanin				JNK	99.90%
MPT0B392				JNK	≥99.0%
IQ-1S free acid	JNK1, Kd: 240 nM	JNK2, Kd: 360 nM	JNK3, Kd: 100 nM		99.35%
Loureirin B				JNK	99.16%
Tomatidine hydrochloride				JNK	≥98.0%
CEP-1347	JNK1				98.50%
IQ-3	JNK1, Kd: 0.24 μM	JNK2, Kd: 0.29 μM	JNK3, Kd: 0.066 μM		99.38%
JTP10-△-TATi TFA	JNK1, IC₅₀: 1.16 μM	JNK2, IC₅₀: 92 nM	JNK3, IC₅₀: 1.2 μM		98.49%
L-JNKI-1				JNK
Indirubin-3′-oxime	JNK1, IC₅₀: 0.8 μM	JNK2, IC₅₀: 1.4 μM	JNK3, IC₅₀: 1 μM		99.49%
(-)-Zuonin A	JNK1, IC₅₀: 1.7 μM	JNK2, IC₅₀: 2.9 μM	JNK3, IC₅₀: 1.74 μM		99.99%
JNK3 inhibitor-4	JNK1, IC₅₀: 143.9 nM	JNK2, IC₅₀: 298.2 nM	JNK3, IC₅₀: 1.0 nM
SX 011	JNK1, IC₅₀: > 300,000 nM	JNK2, IC₅₀: 100 nM			99.33%
JNK-IN-13		JNK2, IC₅₀: 500 nM	JNK3, IC₅₀: 290 nM
JTP10-△-R9 TFA	JNK1, IC₅₀: 1.1 μM	JNK2, IC₅₀: 89 nM	JNK3, IC₅₀: 1.2 μM		99.80%
CC-401				JNK, Ki: 25-50 nM
Ginsenoside Re (Standard)				JNK
Sugiol	JNK1	JNK2
JNK-1-IN-1	JNK1
JNK3 inhibitor-5	JNK1, IC₅₀: 82.7 nM	JNK2, IC₅₀: 29.4 nM	JNK3, IC₅₀: 0.379 nM
JAK3-IN-13	JNK1, IC₅₀: 4728 nM	JNK2, IC₅₀: 2039 nM	JNK3, IC₅₀: 8 nM
JNK-IN-14	JNK1, IC₅₀: 1.82 nM	JNK2, IC₅₀: 10.5 nM	JNK3, IC₅₀: 10.5 nM
SR-3576			JNK3, IC₅₀: 7 nM		≥98.0%
JNK3 inhibitor-3	JNK1, IC₅₀: 147.8 nM	JNK2, IC₅₀: 44 nM	JNK3, IC₅₀: 4.1 nM
TOPK-p38/JNK-IN-1				JNK
MR2938				JNK
JNK3 inhibitor-2	JNK1, IC₅₀: >100 μM	JNK2, IC₅₀: >100 μM	JNK3, IC₅₀: 0.25 μM
JNK-IN-11	JNK1, IC₅₀: 1.8 μM	JNK2, IC₅₀: 21.4 μM	JNK3, IC₅₀: 2.2 μM
YL5084	JNK1, IC₅₀: 2173 nM	JNK2, IC₅₀: 70 nM	JNK3, IC₅₀: 84 nM
Lucidone				JNK
Aloisine A				JNK, IC₅₀: 3-10 μM
JNK3 inhibitor-7	JNK1, IC₅₀: 1039 nM	JNK2, IC₅₀: 973 nM	JNK3, IC₅₀: 53 nM
JNK3 inhibitor-8	JNK1, IC₅₀: >10000 nM	JNK2, IC₅₀: 2203 nM	JNK3, IC₅₀: 21 nM

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)	站点地图隐私声明
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.	沪ICP备15051369号-4

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)

站点地图隐私声明

JNK Inhibitors

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

姓名
邮箱 *

Sorry, but the email address you supplied was invalid.